InnovationsKapital has sold stem cell biopharmaceutical firm Cellartis to French biotech company Cellectis in exchange for cash and shares.
BCEP II follows a long-hold private equity strategy, with an investment period of 15 years
Combined companies will pursue a buy-and-build strategy, acquiring fitness studio chains
Marc Seeger joins the firm's Düsseldorf-based corporate and M&A team from Hengeler Mueller
GP acquires the automotive networked systems business as part of a succession solution